Atossa Therapeutics Inc (ATOS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATOS Annual Balance Sheets →
This page allows investors to track Atossa Therapeutics Inc's balance sheet development across multiple reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent26.09
Restricted Cash and Cash Equivalents, Current0.11
Cash & Short-term Investments26.00
Other Current Assets2.90
Prepaid Expense And Other Assets Current1.79
Total Current Assets31.01
Long-term investments0.11
Other Assets, Noncurrent1.16
Total Assets32.28
Liabilities
Accounts Payable, Current AC1.98
Accrued Liabilities, Current1.38
Other Liabilities, Current2.10
Total Current Liabilities5.45
Total Long-term Debt0.00
Total Liabilities5.45
Stockholders' Equity
Treasury Stock Common Value-1.48
Common Stock Value1.80
Additional Paid In Capital Common Stock291.15
Retained Earnings / Accumulated Deficit-264.64
Other Equity0.00
Common Stockholder's Equity26.83
Total Stockholder's Equity26.83
Liabilities & Stockholder's Equity32.28
4 historic quarters locked

Sign in to unlock the full Atossa Therapeutics Inc balance sheet history.

About Atossa Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-339257

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.